查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594543

核酸增幅检查市场：按技术和应用划分 - 2025-2030 年全球预测

Nucleic Acid Amplification Testing Market by Technique (Probe Amplification Systems, Signal Amplification Systems, Target Amplification Systems), Application (Cancer, Genetic & Mitochondrial Disorders, Infectious Diseases) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年核酸增幅检查市场规模为31.3亿美元，预计2024年将达35.3亿美元，复合年增长率为12.86%，预计2030年将达73亿美元。

核酸增幅检查(NAAT) 是一种重要的分子技术，用于扩增和检测 DNA 或 RNA 的特定序列，对于诊断感染疾病、遗传性疾病和癌症至关重要。对 NAAT 的需求源于其高灵敏度和特异性，可实现早期检测和准确诊断，这对于有效治疗和遏制疾病至关重要。其应用涵盖医疗保健、生物技术和製药，并在诊断、研究和开发中发挥重要作用。最终用途包括医院、诊断实验室、研究机构、生物製药公司等。感染疾病的流行、技术进步以及对个人化医疗的需求不断增长推动了市场成长。 COVID-19 大流行显着提高了人们的认识和采用率，使 NAAT 成为病毒检测的重要工具。新的商机在于自动化和数位技术的持续集成，以提高吞吐量和准确性，并扩大照护现场诊断 (POC) 的范围。然而，市场成长面临高成本、复杂的监管环境以及对熟练人员的需求等挑战。公司可以透过投资研发来降低成本并改善可及性，特别是在服务不足的地区，从而利用机会。与医疗机构的合作和培训计划的投资可以帮助缓解一些挑战。需要创新的领域包括开发用于 POC 测试和即时分析功能的便携式、易于使用的套件。您还可以利用远端医疗和数位医疗技术来简化测试流程和资料管理，从而加速业务成长。市场竞争激烈，有效占领市场占有率需要敏捷性和策略伙伴关係，以跟上快速技术创新的步伐。公司必须专注于永续性和成本效益，以满足​​不断增长的需求，同时解决现有的限制。开拓疾病检测以外的新应用，例如环境监测和农业诊断，可能会开闢进一步的市场潜力。

主要市场统计
基准年[2023] 31.3亿美元
预测年份 [2024] 35.3亿美元
预测年份 [2030] 73亿美元
复合年增长率（%） 12.86%

市场动态：快速发展的核酸增幅检查市场的关键市场洞察

核酸增幅检查市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • COVID-19 和其他传染性细菌病毒的发生率上升
    • 增加对新生物技术诊断开发的投资
    • 扩大诊断设施和实验室
  • 市场限制因素
    • 政府对生物技术诊断实施严格的法规
  • 市场机会
    • NAA 测试的新技术改进
    • 政府为促进 NAA 测试所做的积极努力
  • 市场挑战
    • 缺乏训练有素的专业技术人员且敏感度高

波特五力：驾驭核酸增幅检查市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对核酸增幅检查市场的影响

外部宏观环境因素在塑造核酸增幅检查市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解核酸增幅检查市场的竞争状况

对核酸增幅检查市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV定位矩阵核酸核酸增幅检查市场厂商绩效评估

FPNV定位矩阵是评估核酸增幅检查市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了核酸增幅检查市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对核酸增幅检查市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • COVID-19 和其他传染性细菌病毒的发生率上升
      • 增加对新生物技术诊断开发的投资
      • 扩大诊断设施和实验室的数量
    • 抑制因素
      • 政府对核酸增幅检查实施严格监管
    • 机会
      • NAA 考试的新技术改进
      • 政府为促进 NAA 考试而采取的有利倡议
    • 任务
      • 缺乏训练有素的技术专长和高度敏感性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章核酸增幅检查市场：依技术分类

  • 探针放大系统
  • 讯号放大系统
  • 目标放大系统

第七章核酸增幅检查市场：依应用

  • 癌症
  • 遗传和粒线体疾病
  • 感染疾病
    • 细菌
    • 病毒性的
  • 个人化医疗

第八章 南北美洲核酸增幅检查市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区核酸增幅检查市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲核酸增幅检查市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • GE Healthcare
  • Genomtec SA
  • Grifols, SA
  • Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Jena Bioscience GmbH
  • Lucigen Corporation
  • Mast Group Ltd.
  • Novartis AG
  • OptiGene Limited
  • PREMIER Biosoft
  • QIAGEN GmbH
  • Quidel Corporation
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • TwistDx Limited
Product Code: MRR-AD36CD897FB8

The Nucleic Acid Amplification Testing Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.53 billion in 2024, and is projected to grow at a CAGR of 12.86%, to USD 7.30 billion by 2030.

Nucleic Acid Amplification Testing (NAAT) is a key molecular technique used to amplify and detect specific sequences of DNA or RNA, crucial for diagnosing infectious diseases, genetic disorders, and cancer. NAAT's necessity stems from its high sensitivity and specificity, enabling early detection and accurate diagnosis, which is vital for effective treatment and containment of diseases. Its applications span healthcare, biotechnology, and pharmaceuticals, playing an instrumental role in diagnostics, research, and development. The end-use scope includes hospitals, diagnostic laboratories, research institutions, and biopharmaceutical companies. Market growth is driven by the increasing prevalence of infectious diseases, technological advancements, and rising demand for personalized medicine. The COVID-19 pandemic significantly heightened awareness and adoption, positioning NAAT as an indispensable tool for viral detection. Emerging opportunities lie in the continuous integration of automation and digital technologies to enhance throughput and accuracy, along with expanding the scope in point-of-care (POC) diagnostics. However, market growth faces challenges such as high costs, complex regulatory landscapes, and a need for skilled personnel. Companies can capitalize on opportunities by investing in R&D to lower costs and improve accessibility, particularly in underserved regions. Collaborations with healthcare institutions and investment in training programs can mitigate some challenges. Areas ripe for innovation include the development of portable, user-friendly kits for POC testing and real-time analysis capabilities. Business growth can also be spurred by leveraging telemedicine and digital health technologies to streamline testing processes and data management. The market is competitive, with rapid innovations necessitating agility and strategic partnerships to capture market share effectively. Companies must focus on sustainability and cost-effectiveness to meet the growing demand while addressing existing limitations. Pioneering novel applications beyond disease detection, such as environmental monitoring and agricultural diagnostics, could unlock further market potential.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.53 billion
Forecast Year [2030] USD 7.30 billion
CAGR (%) 12.86%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Amplification Testing Market

The Nucleic Acid Amplification Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of COVID-19 and other infectious bacterial virus
    • Increasing investment for development of new biotechnological diagnostics
    • Expanding number of diagnostic facilities and labs
  • Market Restraints
    • Stringent government regulation imposed on the nucleic acid amplification testing
  • Market Opportunities
    • New technological improvements in NAA testing
    • Favorable government initiative to promote NAA testing
  • Market Challenges
    • Lack of trained technical expertise and high sensitivity

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Amplification Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Amplification Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Amplification Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Amplification Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Amplification Testing Market

A detailed market share analysis in the Nucleic Acid Amplification Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Amplification Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Amplification Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Amplification Testing Market

A strategic analysis of the Nucleic Acid Amplification Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Amplification Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Eiken Chemical Co., Ltd., GE Healthcare, Genomtec SA, Grifols, S.A., Hoffmann-La Roche Ltd., Illumina, Inc., Jena Bioscience GmbH, Lucigen Corporation, Mast Group Ltd., Novartis AG, OptiGene Limited, PREMIER Biosoft, QIAGEN GmbH, Quidel Corporation, Siemens Healthcare GmbH, Sysmex Corporation, and TwistDx Limited.

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Amplification Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Probe Amplification Systems, Signal Amplification Systems, and Target Amplification Systems.
  • Based on Application, market is studied across Cancer, Genetic & Mitochondrial Disorders, Infectious Diseases, and Personalized Medicine. The Infectious Diseases is further studied across Bacterial and Viral.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of COVID-19 and other infectious bacterial virus
      • 5.1.1.2. Increasing investment for development of new biotechnological diagnostics
      • 5.1.1.3. Expanding number of diagnostic facilities and labs
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent government regulation imposed on the nucleic acid amplification testing
    • 5.1.3. Opportunities
      • 5.1.3.1. New technological improvements in NAA testing
      • 5.1.3.2. Favorable government initiative to promote NAA testing
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained technical expertise and high sensitivity
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nucleic Acid Amplification Testing Market, by Technique

  • 6.1. Introduction
  • 6.2. Probe Amplification Systems
  • 6.3. Signal Amplification Systems
  • 6.4. Target Amplification Systems

7. Nucleic Acid Amplification Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Genetic & Mitochondrial Disorders
  • 7.4. Infectious Diseases
    • 7.4.1. Bacterial
    • 7.4.2. Viral
  • 7.5. Personalized Medicine

8. Americas Nucleic Acid Amplification Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Nucleic Acid Amplification Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Nucleic Acid Amplification Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories Inc.
  • 2. Beckman Coulter, Inc.
  • 3. Becton, Dickinson, and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Eiken Chemical Co., Ltd.
  • 7. GE Healthcare
  • 8. Genomtec SA
  • 9. Grifols, S.A.
  • 10. Hoffmann-La Roche Ltd.
  • 11. Illumina, Inc.
  • 12. Jena Bioscience GmbH
  • 13. Lucigen Corporation
  • 14. Mast Group Ltd.
  • 15. Novartis AG
  • 16. OptiGene Limited
  • 17. PREMIER Biosoft
  • 18. QIAGEN GmbH
  • 19. Quidel Corporation
  • 20. Siemens Healthcare GmbH
  • 21. Sysmex Corporation
  • 22. TwistDx Limited

LIST OF FIGURES

  • FIGURE 1. NUCLEIC ACID AMPLIFICATION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NUCLEIC ACID AMPLIFICATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NUCLEIC ACID AMPLIFICATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEIC ACID AMPLIFICATION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEIC ACID AMPLIFICATION TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 146. NUCLEIC ACID AMPLIFICATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. NUCLEIC ACID AMPLIFICATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023